The stool antigen test for detection of Helicobacter pylori after eradication therapy.

Background: Current noninvasive tests to confirm the eradication of Helicobacter pylori must be performed 4 weeks or more after eradication therapy is completed.Objective: To determine whether the stool antigen test, a relatively new noninvasive test for H. pylori, administered at various times afte...

Descripción completa

Detalles Bibliográficos
Publicado en:Annals of Internal Medicine Vol. 136; no. 4; pp. 280 - 289
Autores principales: Vaira D, Vakil N, Menegatti M, van't Hoff B, Ricci C, Gatta L, Gasbarrini G, Quina M, Garcia JMP, van der Ende A, van der Hulst R, Anti M, Duarte C, Gisbert JP, Miglioli M, Tytgat G, Vaira, Dino, Vakil, Nimish, Menegatti, Marcello, van't Hoff, Ben
Formato: commentary consumer/patient teaching materials research tables/charts Journal Article
Publicado: American College of Physicians 2/19/2002
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106924201&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106924201
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00034819
        AIM
      jtl: Annals of Internal Medicine
      issn: 00034819
      maglogo: N
    pubinfo:
      dt: 2/19/2002
      vid: 136
      iid: 4
      pid: 1652
      pub: American College of Physicians
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        106924201
        106924201
        NLM11848725
        2002055302
        10.7326/0003-4819-136-4-200202190-00007
        NLM11848725
        106924201
      ppf: 280
      ppct: 9
      formats:
      tig:
        atl: The stool antigen test for detection of Helicobacter pylori after eradication therapy.
      aug:
        au:
          Vaira D
          Vakil N
          Menegatti M
          van't Hoff B
          Ricci C
          Gatta L
          Gasbarrini G
          Quina M
          Garcia JMP
          van der Ende A
          van der Hulst R
          Anti M
          Duarte C
          Gisbert JP
          Miglioli M
          Tytgat G
          Vaira, Dino
          Vakil, Nimish
          Menegatti, Marcello
          van't Hoff, Ben
        affil: Department of Internal Medicine and Gastroenterology, S. Orsola Hospital, via Massarenti 9, 40138 Bologna, Italy
      sug:
        subj:
          Helicobacter Infections Drug Therapy
          Feces Analysis
          After Care
          Drug Therapy, Combination
          Antibiotics Therapeutic Use
          Patient Education
          Antigens, Bacterial Analysis
          Treatment Failure
          Endoscopy
          Breath Tests
          Predictive Value of Tests
          Sensitivity and Specificity
          Prospective Studies
          Mann-Whitney U Test
          Data Analysis Software
          Confidence Intervals
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Female
          Male
          Funding Source
          Human
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Female
          Male
      ab: Background: Current noninvasive tests to confirm the eradication of Helicobacter pylori must be performed 4 weeks or more after eradication therapy is completed.Objective: To determine whether the stool antigen test, a relatively new noninvasive test for H. pylori, administered at various times after eradication therapy correctly identifies persons with persistent H. pylori infection.Design: Prospective blinded study.Setting: Six clinical centers in the United States and Europe.Patients: 84 H. pylori --infected patients undergoing endoscopy for upper abdominal symptoms.Measurements: At baseline and on day 35 after the completion of triple eradication therapy, all patients underwent endoscopy with histologic examination, rapid urease test and culture, urea breath test, and a stool antigen test. The stool antigen test was also performed on days 3, 7, 15, 21, 28, and 35 after completion of therapy.Results: Compared with the gold-standard endoscopic tests on day 35 after antimicrobial therapy, the urea breath test had a sensitivity of 94% (95% CI, 71% to 100%) and a specificity of 100% (CI, 94% to 100%). The stool antigen test had a sensitivity of 94% (CI, 71% to 100%) and a specificity of 97% (CI, 89% to 100%). On day 7 after treatment, the stool antigen test was predictive of eradication (positive predictive value, 100% [CI, 69% to 100%]; negative predictive value, 91% [CI, 82% to 97%]).Conclusion: A positive result on the stool antigen test 7 days after completion of therapy identifies patients in whom eradication of H. pylori was unsuccessful.
      pubtype: Academic Journal
      doctype:
        commentary
        consumer/patient teaching materials
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N